Related Experiment Video
Updated: May 23, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Pharmacogenetics: a reality or misplaced optimism?
1Senior Lecturer Senior Lecturer, Faculty of Health and Social Care, London South Bank University, Romford, UK. mutsatss@lsbu.ac.uk
Journal of Psychiatric and Mental Health Nursing
|April 20, 2012
Summary
Genetic information is revolutionizing psychotropic medication management. Pharmacogenetics helps predict patient response to psychiatric drugs, improving treatment efficacy and safety.
Area of Science:
- Pharmacogenetics
- Psychiatric Nursing
- Genomic Medicine
Background:
- Individual genetic makeup significantly influences drug metabolism, a concept known for decades.
- Recent advancements enable the clinical application of genetic information in psychotropic medication management.
- Variations in psychotropic drug response exist across racial and ethnic groups, with genetic underpinnings.
Purpose of the Study:
- To review current evidence supporting the use of genetic information in managing psychotropic medications.
- To explore the potential of pharmacogenetics in personalizing psychiatric treatment.
- To examine the impact of these advances on mental health nursing practice and education.
Main Methods:
- Literature review of recent studies on pharmacogenetics in psychotropic medication.
- Analysis of evidence for genetic variations in drug response.
- Examination of available psychiatric pharmacogenetic tests and their clinical utility.
Main Results:
- Genetic variations demonstrably influence patient responses to psychotropic medications.
- Pharmacogenetic testing is emerging for metabolic status, adverse event risk (e.g., agranulocytosis), and drug selection.
- Established pharmacogenetic applications exist in other fields like anticoagulant therapy.
Conclusions:
- Pharmacogenetics holds significant promise for predicting patient response to specific psychotropic drugs and optimal dosages.
- The integration of genetic information is poised to transform mental health nursing education and practice.
- Personalized medicine through pharmacogenetics is becoming a reality in psychiatric care.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...